2020
DOI: 10.1016/j.mcp.2020.101572
|View full text |Cite
|
Sign up to set email alerts
|

miR-544a Stimulates endometrial carcinoma growth via targeted inhibition of reversion-inducing cysteine-rich protein with Kazal motifs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 29 publications
0
6
0
Order By: Relevance
“…Moreover, 35 studies investigated the role of miRNAs in the regulation of tumor growth and EC metastasis in vivo in murine models [ 18 , 19 , 24 , 36 , 41 , 42 , 44 , 45 , 49 , 51 , 52 , 53 , 56 , 62 , 69 , 70 , 72 , 73 , 92 , 93 , 101 , 111 , 117 , 119 , 122 , 126 , 128 , 136 , 137 , 144 , 145 , 151 , 157 , 160 , 166 ]. Eight miRNAs were identified as oncomiRNAs in vivo (miR-106a, miR-107-5p, miR-130b, miR-183, miR-222-3p, miR-494-3p, miR-544a, and miR-652) and 27 as tumor suppressor miRNAs (miR-23a, miR-23b, miR-26a, miR-29a-5p, miR-29b, miR-34a, miR-34b, miR-99a, miR-101, miR-129, miR-142, miR-148b, miR-194, miR-199a/b-5p, miR-200c, miR-204, miR-214-3p, miR-302a-5p, miR-326, miR-361, miR-367-3p, miR-372, miR-449a, miR-490-3p, miR-499a, miR-505, and miR-1827).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Moreover, 35 studies investigated the role of miRNAs in the regulation of tumor growth and EC metastasis in vivo in murine models [ 18 , 19 , 24 , 36 , 41 , 42 , 44 , 45 , 49 , 51 , 52 , 53 , 56 , 62 , 69 , 70 , 72 , 73 , 92 , 93 , 101 , 111 , 117 , 119 , 122 , 126 , 128 , 136 , 137 , 144 , 145 , 151 , 157 , 160 , 166 ]. Eight miRNAs were identified as oncomiRNAs in vivo (miR-106a, miR-107-5p, miR-130b, miR-183, miR-222-3p, miR-494-3p, miR-544a, and miR-652) and 27 as tumor suppressor miRNAs (miR-23a, miR-23b, miR-26a, miR-29a-5p, miR-29b, miR-34a, miR-34b, miR-99a, miR-101, miR-129, miR-142, miR-148b, miR-194, miR-199a/b-5p, miR-200c, miR-204, miR-214-3p, miR-302a-5p, miR-326, miR-361, miR-367-3p, miR-372, miR-449a, miR-490-3p, miR-499a, miR-505, and miR-1827).…”
Section: Resultsmentioning
confidence: 99%
“…Further, we collected data from articles investigating the association between the expression of invasion-related miRNAs in tumor tissue and clinical parameters, including OS, DFS, PFS, FIGO stage, histological grade, myometrial invasion, and lymph node metastases. We identified 51 articles that correlated upregulated expression of 25 miRNAs and downregulated expression of 41 miRNAs with at least one clinical parameter ( Table 4 ) [ 18 , 19 , 24 , 25 , 28 , 29 , 32 , 34 , 37 , 38 , 41 , 44 , 49 , 51 , 52 , 56 , 57 , 58 , 60 , 69 , 70 , 71 , 76 , 77 , 78 , 79 , 81 , 84 , 95 , 99 , 100 , 108 , 110 , 111 , 115 , 117 , 120 , 122 , 130 , 131 , 132 , 147 , 154 , 160 , 175 , 176 , 177 , 178 , …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…LEF1-AS1 contributes to proliferation and invasion by regulating the miR-544a/FOXP1 axis in lung cancer [ 29 ]. MiR-544a stimulates endometrial carcinoma growth via targeted inhibition of reversion-inducing cysteine-rich protein with Kazal motifs [ 30 ]. MiRNA-544a regulates the inflammation in spinal cord injury by inhibiting the expression of NEUROD4 [ 31 ] These results provide a good reference for the further study of miR544a in peri-implantitis or periodontitis.…”
Section: Discussionmentioning
confidence: 99%
“…Although RECK has different signaling pathways of transcriptional regulation [12], accumulating evidence support a role for microRNAs in RECK regulation during the car-cinogenesis processes. It has been reported that RECK is regulated by miR-15a in neuro-blastoma [13], by miR-15b/16, miR-21, miR-372, and miR-373 in colon adenocarcinoma [14], by miR-25 and miR-374b-5p in gastric cancer [15,16], by miR-92a, miR-92b, and miR-96 in lung cancer [17][18][19], by miR-135b and sponging miR-135b in hepatocellular carcinoma [20,21], by miR-182-5p in prostate cancer, in bladder cancer, breast cancer and melanoma [22][23][24][25], by miR-181a-5p, miR-200b, miR-200c and miR-221 in colorectal cancer [26][27][28], by miR-15b-5p in prostate cancer [29], by miR-9 and miR-590-5p in oral squamous cell carcinoma [30,31], by miR-544a in endometrial carcinoma [32], and by miR-30b-3p in glioma [33]. The expression of miR-21 microRNA has been found to be al-tered in almost all types of cancers and it has been classified as an oncogenic microRNA [34].…”
Section: Introductionmentioning
confidence: 99%